New beginnings: There will be blood, or at least, some bumps
This article was originally published in Scrip
Executive Summary
Whether it's bringing a new product to the marketplace or implementing a new program, there's bound to be some bumps along the way, said Dr Mark McClellan, director of the Engelberg Center for Health Care Reform at the Washington think tank Brookings Institute, and former head of the US FDA and the Center for Medicare & Medicaid Services (CMS).